Compartmentalization of angiotensin II generation in the dog heart: Evidence for independent mechanisms in intravascular and interstitial spaces

Journal of Clinical Investigation

Volumn 100, Issue 2, 1997, Pages 253-258

  Dell'Italia, Louis J ^a   Meng, Qing C ^a   Balcells, Eduardo ^a   Wei, Chih Chang ^a   Palmer, Ronald ^b   Hageman, Gilbert R ^b   Durand, Joan ^a   Hankes, Gerald H ^c   Oparil, Suzanne ^a  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c AUBURN UNIVERSITY   (United States)

Author keywords

Angiotensin converting enzyme inhibitors; Angiotensins; Heart; Heart hypertrophy; Left ventricular function

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN I; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; COMPARTMENT MODEL; CONTROLLED STUDY; DOG; HEART; INTERSTITIAL FLUID; NONHUMAN; PRIORITY JOURNAL;

EID: 0030838414     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119529     Document Type: Article

References (37)

1. Yamazaki, T., I. Komuro, S. Kudoh, Y. Zou, I. Shiojima, T. Mizuno, H. Takano, Y. Hiroi, K. Ueki, K. Tobe, et al. 1995. Angiotensin II partly mediates mechanical stress-induced cardiac hypertrophy. Circ. Res. 77:258-265.
2. 1 receptor subtype. Circ. Res. 73:413-423.
3. Brasch, H., L. Sieroslawski, and P. Dominiak. 1993. Angiotensin II increases norepinephrine release from atria by acting on angiotensin subtype 1 receptors. Hypertension (Dallas). 22:699-704.
4. Lindpaintner, K., M. Jin, M.J. Wilhelm, F. Suzuki, W. Linz, B.A. Schoelkens, and D. Ganten. 1988. Intracardiac generation of angiotensin and its physiologic role. Circulation. 77(Suppl.):1-18.
5. Boer, P.M., M. Ruzicka, W. Lear, E. Harmsen, J. Rosenthal, and F.H.H. Leenen. 1994. Stretch-mediated activation of the cardiac renin gene. Am. J. Physiol. (Heart Circ. Physiol. 36). 267:H1630-H1636.
6. Baker, K.M., M. Chemin, S.K. Wixon, and J.F. Aceto. 1990. Reninangiotensin system involvement in pressure-overload cardiac hypertrophy in rats. Am. J. Physiol. (Heart. Circ. Physiol. 28). 259.-H324-H332.
7. 1 expression. Hypertension (Dallas). 23:587-592.
8. Schunkert, H., V.J. Dzau, S.S. Tang, A.T. Hirsch, C.S. Apstein, and B.H. Lorell. 1990. Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy: effects on coronary resistance, contractility and relaxation. J. Clin. Invest. 86:1913-1920.
9. Iwai, N., H. Shimoike, and M. Kinoshita. 1995. Cardiac renin-angiotensin system in the hypertrophied heart. Circulation. 92:2690-2696.
10. Pieruzzi, F., Z.A. Abassi, and H.R. Keiser. 1995. Expression of reninangiotensin system components in the heart, kidneys, and lungs of rats with experimental heart failure. Circulation. 92:3105-3112.
11. Pfeffer, M.A., E. Braunwald, L.A. Moye, L. Basta, E.J. Brown, Jr., T.E. Cuddy, B.R. Davis, E.M. Geltman, S. Goldman, G.C. Flaker, et al. 1992. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N. Engl. J. Med. 327:669-677.
12. The SOLVD Investigators. 1991. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N. Engl. J. Med. 327:685-691.
13. Pitt, B., R. Segal, F.A. Martinez, G. Meurers, A.J. Cowley, I. Thomas, P.C. Deedwania, D.E. Ney, D.B. Snavely, and P.I. Chang, on behalf of the ELITE STUDY Investigators. 1997. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet. 349:747-752.
14. Dzau, V.J. 1989. Multiple pathways of angiotensin production in the blood vessel wall: evidence, possibilities and hypotheses. J. Hypertens. 7:933-936.
15. Urata, H., B. Healy, R.W. Stewart, F.M. Bumpus, and A. Husain. 1990. Angiotensin II-forming pathways in normal and failing human hearts. Circ. Res. 66:883-890.
16. Dell'Italia, L.J., Q.C. Meng, E. Balcells, I.M. Straeter-Knowlen, G.H. Hankes, R. Dillon, R.E. Cartee, R. Orr, S.P. Bishop, S. Oparil, and T. Elton. 1995. Increased ACE and chymase-like activity in cardiac tissue of dogs with chronic mitral regurgitation. Am. J. Physiol. (Heart Circ. Physiol. 38). 269: H2065-H2073.
17. Balcells, E., Q.C. Meng, G. Hageman, R.W. Palmer, J. Durand, and L.J. Dell'Italia. 1996. Angiotensin II formation in dog heart is mediated by different pathways in vivo and in vitro. Am. J. Physiol. (Heart Circ. Physiol. 38). 271: H417-H471.
18. Urata, H., K.D. Boehm, A. Philip, A. Kinoshita, J. Gabrovsek, F.M. Bumpus, and A. Hussain. 1993. Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart. J. Clin. Invest. 91:1269-1281.
19. Johnston, C.I. 1994. Tissue angiotensin converting enzyme in cardiac and vascular hypertrophy, repair, and remodeling. Hypertension (Dallas). 23: 258-268.
20. Van Wylen, D.G.L., T.S. Park, R. Rubio, and R.M. Berne. 1986. Increase in cerebral interstitial fluid adenosine concentration during hypoxia, local potassium infusion, and ischemia. J. Cereb. Blood Flow Metab. 6:522-528.
21. Robinson, T.E., and J.B. Justice. 1991. Microdialysis in the neurosciences. Elsevier, Amsterdam, Holland. 450 pp.
22. Siragy, H.M., N.L. Howell, N.V. Ragsdale, and R.M. Carey. 1995. Renal interstitial fluid angiotensin. Modulation by anesthesia, epinephrine, sodium depletion, and renin inhibition. Hypertension. 25:1021-1024.
23. Van Wylen, D.G.L., J. Willis, J. Sodhi, R.J. Weiss, R.D. Lasley, and R.M. Mentzer. 1990. Cardiac microdialysis to estimate interstitial adenosine and coronary blood flow. Am. J. Physiol.(Heart Circ. Physiol. 27). 258:H1642-H1649.
24. Wang, T., R.M. Mentzer, and D.G.L. Van Wylen. 1992. Interstitial adenosine with dipyridamole: effect of adenosine receptor blockade and adenosine deaminase. Am. J. Physiol. (Heart Circ. Physiol. 32). 263:H552-H558.
25. Wang, T., J. Sodhi, R.M. Mentzer, and D.G.L. Van Wylen. 1994. Changes in interstitial adenosine during hypoxia: relationship to oxygen supply, demand imbalance, and effects of adenosine deaminase. Cardiovasc. Res. 28: 1320-1325.
26. Meng, Q.C., J. Durand, Y. Chen, and S. Oparil. 1993. Simplified method for quantification of angiotensin peptides in tissue. J. Chromatogr. 614:19-25.
27. Meng, Q.C., J. Durand, Y. Chen, and S. Oparil. 1995. Effects of dietary salt on angiotensin peptides in kidney. J. Am. Soc. Nephrol. 6:1209-1215.
28. Meng, Q.C., E. Balcells, L. Dell'Italia, and S. Oparil. 1995. Sensitive method for quantitation of angiotensin-converting enzyme (ACE) activity in tissue. Biochem. Pharmacol. 50:1445-1450.
29. Olson, R.A., and R. Bunger. 1987. Metabolic control of coronary blood flow. Prog. Cardiovasc: Dis. 29:369-287.
30. Sadoshima, J., Y. Xu, H.S. Slayter, and S. Izumo. 1993. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell. 75:977-984.
31. Kinoshita, A., H. Urata, F.M. Bumpus, and A. Husain. 1991. Multiple determinants for the high substrate specificity of an angiotensin-forming chymase from the human heart. J. Biol. Chem. 266:19192-19197.
32. Husain, A., A. Kinoshita, S.S. Sung, H. Urata, and F.M. Bumpus. 1994. Human heart chymase. In The Cardiac Renin-Angiotensin System. K. Lindpaintner and D. Ganten, editors. Futura Publishing Co., Inc., Armonk, NY. 309-332.
33. Noda, K., M. Sasaguri, M. Ideishi, M. Ikeda, and K. Arakawa. 1993. Role of locally formed angiotensin II and bradykinin in the reduction of myocardial infarct size in dogs. Circ. Res. 27:334-340.
34. Hoit, B., Y. Shao, A. Kinoshita, M. Gabel, A. Husain, and R.A. Walsh. 1995. Effects of angiotensin II generated by an angiotensin converting enzyme-independent pathway on left ventricular performance in the conscious baboon. J. Clin. Invest. 95:1519-1527.
35. Danser, A.H.J., M.M.G. Koning, P.J.J. Admiraal, F.H.M. Derkx, P.D. Verduow, and M.A.D.H. Schalekamp. 1992. Metabolism of angiotensin I by different tissues in the intact animal. Am. J. Physiol. (Heart Circ. Physiol. 32). 263:H418-H428.
36. Bailie, M.D., F.C. Rector, and D.W. Seldin. 1971. Angiotensin II in arterial and renal venous plasma and renal lymph in the dog. J. Clin. Invest. 50:119-126.
37. Nees, S., V. Herzog, B.F. Becker, M. Brock, C. Des Rosiers, and E. Gerlach. 1985. The coronary endothelium: a highly active metabolic barrier for adenosine. Basic Res. Cardiol. 80:515-529.